James Mond, CSO/CMO at ADMA BIOLOGICS, INC. (ADMA), bought 770 shares at $6.50 ($5K) on 2016-05-03, disclosed to the SEC on 2016-05-05.
Open-market purchase of $5k ADMA by CSO/CMO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ADMA | BUY | 2020-02-11 | $15K | — | Filing → |
| ADMA | BUY | 2019-05-21 | $18K | — | Filing → |
| ADMA | BUY | 2017-11-13 | $22K | — | Filing → |